Literature DB >> 20093497

Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.

Angela Stroope1, Brynn Radtke, Bing Huang, Tatyana Masyuk, Vicente Torres, Erik Ritman, Nicholas LaRusso.   

Abstract

Polycystic liver diseases, the most important of which are autosomal dominant and autosomal recessive polycystic kidney diseases, are incurable pathological conditions. Animal models that resemble human pathology in these diseases provide an opportunity to study the mechanisms of cystogenesis and to test potential treatments. Here we demonstrate that Pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease, developed hepatic cysts. As assessed by micro-computed tomography scanning of intact livers and by light microscopy of hepatic tissue, hepatic cystic volumes increased from 12.82+/-3.16% (5- to 8-month-old mice) to 21.58+/-4.81% (9- to 12-month-old mice). Renal cystogenesis was more severe at early stages of disease: in 5- to 7-month-old mice, cystic volumes represented 40.67+/-5.48% of kidney parenchyma, whereas in older mice cysts occupied 31.04+/-1.88% of kidney parenchyma. Mild fibrosis occurred only in liver, and its degree was unchanged with age. Hepatic cysts were lined by single or multiple layers of squamous cholangiocytes. Cystic cholangiocyte cilia were short and malformed, whereas in renal cysts they appeared normal. In Pkd2ws25/- mice, mitotic and apoptotic indices in both kidney and liver were increased compared with wild-type mice. In conclusion, Pkd2ws25/- mice exhibit hepatorenal pathology resembling human autosomal dominant polycystic kidney disease and represent a useful model to study mechanisms of cystogenesis and to evaluate treatment options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093497      PMCID: PMC2832149          DOI: 10.2353/ajpath.2010.090658

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

Review 1.  Cystic kidney diseases: learning from animal models.

Authors:  Evelyne Fischer; Lionel Gresh; Andreas Reimann; Marco Pontoglio
Journal:  Nephrol Dial Transplant       Date:  2004-11       Impact factor: 5.992

2.  Polycystic liver disease: new insights into disease pathogenesis.

Authors:  Tatyana Masyuk; Nicholas LaRusso
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

Review 3.  Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities.

Authors:  V E Torres; P C Harris
Journal:  J Intern Med       Date:  2007-01       Impact factor: 8.989

4.  Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene.

Authors:  C Boulter; S Mulroy; S Webb; S Fleming; K Brindle; R Sandford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

Authors:  D J Lager; Q Qian; R J Bengal; M Ishibashi; V E Torres
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

6.  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Vicente E Torres; Peter C Harris; Nicholas F Larusso
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

7.  Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.

Authors:  Si-Tse Jiang; Yuan-Yow Chiou; Ellian Wang; Hsiu-Kuan Lin; Yuan-Ta Lin; Ying-Chih Chi; Chi-Kuang Leo Wang; Ming-Jer Tang; Hung Li
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

8.  Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.

Authors:  T Sanzen; K Harada; M Yasoshima; Y Kawamura; M Ishibashi; Y Nakanuma
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

9.  Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

Authors:  Jesús M Banales; Tatyana V Masyuk; Pamela S Bogert; Bing Q Huang; Sergio A Gradilone; Seung-Ok Lee; Angela J Stroope; Anatoliy I Masyuk; Juan F Medina; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

Review 10.  Cholangiociliopathies: genetics, molecular mechanisms and potential therapies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

View more
  16 in total

1.  Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Christopher J Ward; Sergio A Gradilone; Jesus M Banales; Tatyana V Masyuk; Brynn Radtke; Patrick L Splinter; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

Review 2.  The extracellular matrix and ciliary signaling.

Authors:  Tamina Seeger-Nukpezah; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2012-07-19       Impact factor: 8.382

Review 3.  Polycystic liver diseases: advanced insights into the molecular mechanisms.

Authors:  Maria J Perugorria; Tatyana V Masyuk; Jose J Marin; Marco Marzioni; Luis Bujanda; Nicholas F LaRusso; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 46.802

4.  Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease.

Authors:  Karen M Peterson; Federico Franchi; Darrel L Loeffler; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Amir Lerman; Martin Rodriguez-Porcel
Journal:  Am J Nephrol       Date:  2013-08-30       Impact factor: 3.754

5.  Polycystic kidneys have decreased vascular density: a micro-CT study.

Authors:  Rende Xu; Federico Franchi; Brent Miller; John A Crane; Karen M Peterson; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Martin Rodriguez-Porcel
Journal:  Microcirculation       Date:  2013-02       Impact factor: 2.628

6.  Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

Authors:  Tatyana V Masyuk; Brynn N Radtke; Angela J Stroope; Jesús M Banales; Anatoliy I Masyuk; Sergio A Gradilone; Gabriella Bedekovicsne Gajdos; Natasha Chandok; Jason L Bakeberg; Christopher J Ward; Erik L Ritman; Hiroaki Kiyokawa; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

7.  Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.

Authors:  Tatyana V Masyuk; Seung-Ok Lee; Brynn N Radtke; Angela J Stroope; Bing Huang; Jesús M Banales; Anatoliy I Masyuk; Patrick L Splinter; Sergio A Gradilone; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2013-11-07       Impact factor: 4.307

8.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

9.  The zebrafish as a model to study polycystic liver disease.

Authors:  Pamela S Tietz Bogert; Bing Q Huang; Sergio A Gradilone; Tetyana V Masyuk; Gary L Moulder; Stephen C Ekker; Nicholas F Larusso
Journal:  Zebrafish       Date:  2013-05-13       Impact factor: 1.985

10.  A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.

Authors:  Kevin R Kipp; Mina Rezaei; Louis Lin; Elyse C Dewey; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.